Hanmi Pharm cruising with global clinical trials of 3 next-gen anticancer drugs
The research data about drug candidates for next-generation anticancer drugs developed by Hanmi Pharm was presented at the 2018 American Society of Clinical Oncology held in Chicago between the last 1st and 5th.
The drug candidates for new anticancer drugs presented at the ASCO were: Spectrum Ph...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.